FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns a composition and a technology of finished dosage forms of phospholipid nanoparticles of the size of 25 nm. The preparation is intended for oral administration for the purpose of therapy of lipid storage disease as a hypocholesterolemic agent. An infusion form is presented to be applied in injections in therapy of toxic and pre-comatose states. The phospholipid therapeutic composition for lipid storage disease and hepatic comatose and pre-comatose state in the form of the phospholipid nanoparticles of the size of 15-25 nm contains phosphatidyl choline, phosphatidyl ethanolamine and maltose. A method for making said phospholipid therapeutic composition consists in the fact that phospholipid, phosphatidyl ethanolamine and maltose are suspended in water, and the prepared suspension is exposed to a number of microfluidisation cycles at pressure 1700-1900+10% bar, temperature 40-55°C to be lyophilised.
EFFECT: preparations represent long stored lyophilised powders.
4 cl, 3 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION BASED ON DOXORUBICINE AND PHOSPHOLIPID NANOPARTICLES FOR TREATMENT OF ONCOLOGIC DISEASES | 2009 |
|
RU2411935C1 |
BASED ON BOTANICAL PHOSPHOLIPIDS NANOSYSTEM FOR ACTUATION OF BIOLOGICALLY ACTIVE COMPOUNDS, AND METHOD OF ITS MANUFACTURE (VERSIONS) | 2009 |
|
RU2391966C1 |
COMPOSITION OF DIHYDROQUERCETINE ENCLOSED IN PHOSPHOLIPID NANOPARTICLES | 2013 |
|
RU2536208C1 |
PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
METHOD FOR PREPARING INJECTION MEDICINAL FORMULATION OF PHOSPHOLIPID PREPARATION "FOSFOGLIV" FOR TREATMENT AND PROPHYLAXIS OF ACUTE AND CHRONIC HEPATIC DISEASES | 2005 |
|
RU2304430C2 |
COMPOSITION EXHIBITING PROPERTY FOR BIOLOGICAL MEMBRANE REPAIRING | 1998 |
|
RU2133122C1 |
NATURAL PHOSPHOLIPID AGENT | 2008 |
|
RU2367443C1 |
CURATIVE-PROPHYLACTIC COMPOSITION INCLUDING COMBINATIONS OF SOYBEAN PHOSPHOLIPID COMPLEX AND EXTRACTS OF MEDICINAL PLANTS, AND BIOLOGICALLY ACTIVE ADDITIVE BASED UPON THIS COMPOSITION | 2003 |
|
RU2252029C1 |
METHOD FOR SELECTION OF REHABILITATION THERAPY FOR PATIENTS WITH CHRONICAL CHOLECYSTITIS IN REMISSION PHASE | 2007 |
|
RU2347571C2 |
PHARMACEUTIC COMPOSITION INCLUDING ARBIDOL IN COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2009 |
|
RU2411942C2 |
Authors
Dates
2012-04-27—Published
2010-12-30—Filed